Stevens Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Stevens Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-41,955	Closed	-$7.25M	–	1405
2015 Q1	$7.25M	Buy	+41,955	New	+$6.16M	0.26%	109
2014 Q2	–	Sell	-67,686	Closed	-$7.01M	–	1493
2014 Q1	$7.01M	Buy	+67,686	New	+$6.93M	0.19%	130
2013 Q4	–	Sell	-20,651	Closed	-$1.38M	–	1405
2013 Q3	$1.38M	Buy	20,651 +104	+0.5%	+$7.17K	0.04%	415
2013 Q2	$1.36M	Buy	+20,547	New	+$1.18M	0.05%	392

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Stevens Capital Management's SLXP Position: Q2 2015 in Review

Stevens Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 41,955 shares — an estimated $7.25M sold.

Stevens Capital Management first reported a position in SLXP in Q2 2013 and held it in 4 quarters. The position peaked at $7.25M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Stevens Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Stevens Capital Management sold 41,955 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $7.25M.
Stevens Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 4 quarters.
Stevens Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $7.25M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Stevens Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.